SBIR/STTR Research Award
Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation
Award amount
$2,550,000Program and phase
SBIR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Redbud Labs, Inc.
- Proposal award date
- 2024-07-10
- Contract end date
- 2026-06-30
- UEI
- KJGXVMFV9U14
- Solicitation number
- PA20-272
- Topic code
- 400
Research abstract
Project Summary/Abstract SBIR Phase II Award Number: 2R44GM148126-02A1 Award Title: Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation Redbud Labs is requesting TABA supplemental funding to support commercialization planning for its SBIR Phase II project focused on automated extraction of nucleic acids from FFPE tissue samples. The proposed activities include external market research, voice-of-customer interviews, competitive landscape analysis, and development of strategic messaging and commercialization collateral. These efforts will help validate market demand, inform go-to-market strategy, and accelerate adoption of Redbud’s microfluidic FFPE platform. The work will be performed by i5 BioPartners and complements the technical R&D supported under the parent award.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- System for unitary automation of library preparation
- Rapid point-of-care molecular test for HCV VL
- IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE STERILIZATION AND PRODUCE AN INSTRUMENT DESIGNED WITH PORTABILITY AND R
- Point-of-care HIV viral load system using RPA and MXR
- Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
25 SBIR/STTR records share this UEI (2012–2024). Reported award amounts total $25,418,736. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation